{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:16:54Z","timestamp":1790813814986,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Considering the increased cancer patient survivorship, the focus is now on addressing the impacts of treatment on quality of life. In young people, altered reproductive function is a major issue and its effects in young males are largely neglected by novel research. To improve clinician awareness, we systematically reviewed side effects of chemotherapy for Hodgkin  lymphoma (HL) in young males.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The review was prospectively registered (PROSPERO N. CRD42019122868). Three databases (Medline via PUBMED, SCOPUS, and Cochrane Library) were searched for studies featuring males aged 13-51-years who underwent chemotherapy for HL using ABVD (Adriamycin\u00ae (doxorubicin), bleomycin, vinblastine, and dacarbazine) or BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisolone) regimens. These chemotherapy regimens were compared against each other using sperm characteristics, FSH, and inhibin B levels to measure fertility levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data were extracted from five studies featuring 1344 patients. 6 months post-ABVD saw marked deterioration in sperm count, further reduced by more cycles (P\u2009=\u20090.05). Patients treated with BEACOPP rather than ABVD were more prone to oligospermia. Receiving fewer cycles of both regimens increased the likelihood of sperm production recovering. Patients treated with 6-8 cycles of BEACOPP did not recover spermiogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ABVD and BEACOPP regimens significantly reduce fertility function to varying effects depending on treatment duration. ABVD temporarily causes significant reductions in male fertility, whereas BEACOPP\u2019s effects are more permanent. Therefore, clinicians should discuss fertility preservation with male patients receiving infertility-inducing gonadotoxic therapy. Further high-quality studies are required to more adequality describe the risk to fertility by chemotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12094-020-02483-8","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T17:03:17Z","timestamp":1600362197000},"page":"1067-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["ABVD and BEACOPP regimens\u2019 effects on fertility in young males with Hodgkin lymphoma"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5289-8890","authenticated-orcid":false,"given":"M. S. A.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Brunckhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wrench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"4","key":"2483_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2483_CR2","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3324\/haematol.2011.045856","volume":"96","author":"S Harel","year":"2011","unstructured":"Harel S, Ferm\u00e9 C, Poirot C. Management of fertility in patients treated for Hodgkin's lymphoma. Haematologica. 2011;96(11):1692\u20139.","journal-title":"Haematologica"},{"key":"2483_CR3","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.12659\/MSM.913513","volume":"25","author":"L Fu","year":"2019","unstructured":"Fu L, et al. Sperm cryopreservation for male cancer patients: more than 10 years of experience, in Beijing China. Med Sci Monit. 2019;25:3256\u201361.","journal-title":"Med Sci Monit"},{"issue":"2","key":"2483_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","volume":"31","author":"K Behringer","year":"2013","unstructured":"Behringer K, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31(2):231\u20139.","journal-title":"J Clin Oncol"},{"issue":"SUPPL.","key":"2483_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ejogrb.2003.11.002","volume":"113","author":"GM Colpi","year":"2004","unstructured":"Colpi GM, et al. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol. 2004;113(SUPPL.):S2\u2013S6.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2483_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.soncn.2014.11.006","volume":"31","author":"P Patterson","year":"2015","unstructured":"Patterson P, et al. Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs. 2015;31(1):53\u20139.","journal-title":"Semin Oncol Nurs"},{"issue":"6","key":"2483_CR7","first-page":"7212","volume":"16","author":"K Kamimura","year":"2018","unstructured":"Kamimura K, et al. Cancers among adolescents and young adults at one institution in Japan. Oncol Lett. 2018;16(6):7212\u201322.","journal-title":"Oncol Lett"},{"issue":"3","key":"2483_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.soncn.2015.05.006","volume":"31","author":"SL Docherty","year":"2015","unstructured":"Docherty SL, et al. The adolescent and young adult with cancer: a developmental life course perspective. Semin Oncol Nurs. 2015;31(3):186\u201396.","journal-title":"Semin Oncol Nurs"},{"issue":"SUPPL.","key":"2483_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jsm.12050","volume":"10","author":"LA Jacobs","year":"2013","unstructured":"Jacobs LA, Pucci DA. Adult survivors of childhood cancer: the medical and psychosocial late effects of cancer treatment and the impact on sexual and reproductive health. J Sexual Med. 2013;10(SUPPL.):120\u20136.","journal-title":"J Sexual Med"},{"key":"2483_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/CMAR.S154819","volume":"10","author":"A Traila","year":"2018","unstructured":"Traila A, et al. Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era. Cancer Manag Res. 2018;10:1517\u201326.","journal-title":"Cancer Manag Res"},{"key":"2483_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0545-7","volume":"14","author":"M Lambertini","year":"2016","unstructured":"Lambertini M, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1\u20131.","journal-title":"BMC Med"},{"issue":"10091","key":"2483_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, et al. Non-hodgkin lymphoma. Lancet. 2017;390(10091):298\u2013310.","journal-title":"Lancet"},{"key":"2483_CR13","first-page":"CD007941","volume":"5","author":"N Skoetz","year":"2017","unstructured":"Skoetz N, et al. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev. 2017;5:CD007941.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2483_CR14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"1","key":"2483_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cen.13350","volume":"87","author":"DJ Handelsman","year":"2017","unstructured":"Handelsman DJ. Sex differences in athletic performance emerge coinciding with the onset of male puberty. Clin Endocrinol (Oxf). 2017;87(1):68\u201372.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2483_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MOU.0000000000000256","volume":"26","author":"M Khera","year":"2016","unstructured":"Khera M. Male hormones and men's quality of life. Curr Opin Urol. 2016;26(2):152\u20137.","journal-title":"Curr Opin Urol"},{"issue":"Suppl 1","key":"2483_CR17","first-page":"1","volume":"22","author":"C eaVuichoud","year":"2015","unstructured":"eaVuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22(Suppl 1):1\u20136.","journal-title":"Can J Urol"},{"issue":"5","key":"2483_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bjh.14734","volume":"178","author":"EJ Dann","year":"2017","unstructured":"Dann EJ, et al. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET\/CT is beneficial: a prospective multicentre trial of 355 patients. Br J Haematol. 2017;178(5):709\u201318.","journal-title":"Br J Haematol"},{"issue":"2","key":"2483_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bjh.15566","volume":"184","author":"PJ Br\u00f6ckelmann","year":"2019","unstructured":"Br\u00f6ckelmann PJ, et al. Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom. Br J Haematol. 2019;184(2):202\u201314.","journal-title":"Br J Haematol"},{"key":"2483_CR20","unstructured":"Sterne JAC, HM, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF. ROBINS."},{"issue":"3","key":"2483_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10815-015-0636-6","volume":"33","author":"L Boltezar","year":"2016","unstructured":"Boltezar L, Pintaric K, Jezersek Novakovic B. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey. J Assist Reprod Genet. 2016;33(3):325\u201333.","journal-title":"J Assist Reprod Genet"},{"issue":"19","key":"2483_CR22","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.2006.10.2020","volume":"25","author":"MAE Van der Kaaij","year":"2007","unstructured":"Van der Kaaij MAE, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'\u00c9tude des Lymphomes de l'Adulte. J Clin Oncol. 2007;25(19):2825\u201332.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2483_CR23","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/humrep\/15.9.1985","volume":"15","author":"R Tal","year":"2000","unstructured":"Tal R, et al. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 2000;15(9):1985\u20138.","journal-title":"Hum Reprod"},{"issue":"1","key":"2483_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2007-02-073544","volume":"111","author":"M Sieniawski","year":"2008","unstructured":"Sieniawski M, et al. Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). Blood. 2008;111(1):71\u20136.","journal-title":"Blood"},{"issue":"4","key":"2483_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.fertnstert.2009.05.068","volume":"94","author":"C O'Flaherty","year":"2010","unstructured":"O'Flaherty C, et al. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steril. 2010;94(4):1374\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"2483_CR26","first-page":"263","volume":"31","author":"D Paoli","year":"2016","unstructured":"Paoli D, et al. Spermatogenesis in Hodgkin's lymphoma patients: A retrospective study of semen quality before and after different chemotherapy regimens. Hum Reprod. 2016;31(2):263\u201372.","journal-title":"Hum Reprod"},{"issue":"3","key":"2483_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.6004\/jnccn.2016.0035","volume":"14","author":"JM Salsman","year":"2016","unstructured":"Salsman JM, et al. Documentation of fertility preservation discussions for young adults with cancer: examining compliance with treatment guidelines. J Natl Compr Canc Netw. 2016;14(3):301\u20139.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2483_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/jayao.2015.0024","volume":"5","author":"C Benedict","year":"2016","unstructured":"Benedict C, Shuk E, Ford JS. Fertility issues in adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol. 2016;5(1):48\u201357.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"22","key":"2483_CR29","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1182\/bloodadvances.2017008748","volume":"1","author":"JM Kahn","year":"2017","unstructured":"Kahn JM, et al. Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes. Blood Adv. 2017;1(22):1945\u201358.","journal-title":"Blood Adv"},{"issue":"5","key":"2483_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s11764-016-0527-6","volume":"10","author":"M Barnett","year":"2016","unstructured":"Barnett M, et al. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Survivorship Res Pract. 2016;10(5):814\u201331.","journal-title":"J Cancer Survivorship Res Pract"},{"issue":"6","key":"2483_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/humrep\/dez043","volume":"34","author":"H Valli-Pulaski","year":"2019","unstructured":"Valli-Pulaski H, et al. Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers. Hum Reprod. 2019;34(6):966\u201377.","journal-title":"Hum Reprod"},{"key":"2483_CR32","first-page":"27","volume":"12","author":"M Vermeulen","year":"2019","unstructured":"Vermeulen M, et al. Role of stem cells in fertility preservation: current insights. Stem Cells Cloning. 2019;12:27\u201348.","journal-title":"Stem Cells Cloning"},{"issue":"3","key":"2483_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ucl.2019.04.010","volume":"46","author":"RC Sineath","year":"2019","unstructured":"Sineath RC, Mehta A. Preservation of fertility in testis cancer management. Urol Clin North Am. 2019;46(3):341\u201351.","journal-title":"Urol Clin North Am"},{"issue":"6","key":"2483_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10147-016-0998-5","volume":"21","author":"T Shin","year":"2016","unstructured":"Shin T, et al. Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy. Int J Clin Oncol. 2016;21(6):1167\u201371.","journal-title":"Int J Clin Oncol"},{"key":"2483_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.urolonc.2019.02.009","volume":"38","author":"JA Halpern","year":"2019","unstructured":"Halpern JA, Hill R, Brannigan RE. Guideline based approach to male fertility preservation. Urol Oncol. 2019;38:31\u20135.","journal-title":"Urol Oncol"},{"issue":"3","key":"2483_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.fertnstert.2017.05.024","volume":"108","author":"F Martinez","year":"2017","unstructured":"Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017;108(3):407\u2013415.e11.","journal-title":"Fertil Steril"},{"issue":"23","key":"2483_CR37","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","volume":"28","author":"C Mauz-Korholz","year":"2010","unstructured":"Mauz-Korholz C, et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol. 2010;28(23):3680\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02483-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:20:33Z","timestamp":1631834433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2483"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02483-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The article does not contain any human or animal studies by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}